文献速递心外重症与机械循环支持

心脏移植后原发性移植物衰竭体外膜氧合治疗的改进

Improvements in Extracorporeal Membrane Oxygenation for Primary Graft Failure After Heart Transplant.
PubMed 文献 · Ann Thorac Surg · 2022-04-14

单中心回顾性队列研究纳入2013至2020年因原发性移植物衰竭接受VA-ECMO的成人心脏移植患者,按2017年前后分层,比较脱机生存等结局。2017年后各时间点生存率显著改善,脱机生存由61%升至100%;多变量Cox回归显示2017年后移植与死亡风险降低相关(HR 0.209,95%CI 0.06-0.71,P=.01)。

要点

  • 2017年后采用客观VA-ECMO指征、部分流量支持及烟囱 graft 动脉插管策略。
  • 脱机生存2017年前61% vs 2017年后100%,各时间点生存显著改善。
  • 2017年后移植是多变量Cox模型中死亡风险降低的预测因素(HR 0.209)。

核心结论

  • 新的VA-ECMO策略显示出合理的生存率,且较既往系统有显著改善。

研究设计与样本

  • 单中心回顾性队列研究,纳入2013至2020年因原发性移植物衰竭接受VA-ECMO的成人心脏移植患者,按2017年前后分层。

主要发现

  • 276例心脏移植受者中识别出39例需VA-ECMO的严重原发性移植物衰竭患者。
  • 移植物衰竭发生率2017年前为13%(18/135),2017年后为15%(21/141)。
  • 脱机生存2017年前61% vs 2017年后100%,各时间点生存率2017年后显著改善。
  • 多变量Cox回归控制其他因素后,2017年后移植与死亡风险降低相关(HR 0.209,95%CI 0.06-0.71,P=.01)。
  • 其他恢复相关次要结局未观察到显著差异。

关键数值与推荐

  • 2017年本中心采用额外的VA-ECMO客观标准、部分流量支持,并将中心插管改为头臂、腋或主动脉的烟囱 graft 动脉插管。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe primary graft failure is a life-threatening complication of heart transplantation that may require venoarterial extracorporeal membrane oxygenation (VA-ECMO) support. Surgical practices and management strategies regarding VA-ECMO vary between and within centers. METHODS: We performed a single-center retrospective cohort study on adult patients who received VA-ECMO for primary graft failure between 2013 and 2020. Clinical data were obtained from chart review and national databases. Patients were stratified by transplantation before or after 2017, when our center adopted additional objective criteria for VA-ECMO, adopted partial-flow support, and changed from central cannulation to chimney graft arterial cannulation of brachiocephalic, axillary, or aorta. The primary outcome was survival to device weaning. Secondary outcomes were survival to discharge, survival to 1 year, complications on support, and time to sedation weaning and extubation. RESULTS: From 276 heart transplant recipients, 39 severe primary graft failure patients requiring VA-ECMO were identified. Incidence of graft failure was 13% (n = 18 of 135) pre-2017 and 15% (n = 21 of 141) post-2017. Survival at all time points improved significantly after 2017, with greatest difference in survival to device weaning (61% pre-2017 vs 100% post-2017). After controlling for other factors in multivariable Cox regression modeling, transplantation after 2017 was a predictor of reduced mortality (hazard ratio, 0.209; 95% CI, 0.06-0.71; P = .01). Significant differences were not observed in other secondary outcomes of recovery. CONCLUSIONS: The new VA-ECMO strategy displayed reasonable survival and a remarkable improvement from the prior system.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Guo A, Kotkar K, Schilling J, et al. Improvements in Extracorporeal Membrane Oxygenation for Primary Graft Failure After Heart Transplant. Ann Thorac Surg. 2022. PMID: 35430222. doi:10.1016/j.athoracsur.2022.03.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。